Myomo, Inc. Files Form 144 with the SEC – What You Need to Know
In a recent SEC filing, Myomo, Inc. (0001369290) submitted a Form 144 indicating insider activity. Form 144 is filed with the Securities and Exchange Commission to report the sale of restricted stock by company affiliates. This filing is significant as it provides transparency regarding any potential selling of restricted shares by insiders, which can impact the company’s stock price and investor sentiment.
Myomo, Inc. is a medical robotics company that develops and produces myoelectric orthotics for people with neuromuscular disorders. These devices help restore mobility and improve the quality of life for individuals with neurological conditions. Myomo’s innovative technology has garnered attention in the healthcare industry for its potential to revolutionize rehabilitation practices.
For more information about Myomo, Inc. and its groundbreaking work in medical robotics, please visit their website at https://www.myomo.com/.
Read More:
Myomo, Inc. Submits Form 144 Filing – Stay Updated on Latest SEC Activity
